You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

VEPESID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vepesid patents expire, and when can generic versions of Vepesid launch?

Vepesid is a drug marketed by Strides Pharma and Corden Pharma and is included in two NDAs.

The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vepesid

A generic version of VEPESID was approved as etoposide by HIKMA on July 17th, 1995.

  Try a Trial

Drug patent expirations by year for VEPESID
Recent Clinical Trials for VEPESID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Incyte CorporationPhase 2
ADC TherapeuticsPhase 2
Joseph TuscanoPhase 2

See all VEPESID clinical trials

US Patents and Regulatory Information for VEPESID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VEPESID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VEPESID

See the table below for patents covering VEPESID around the world.

Country Patent Number Title Estimated Expiration
Switzerland 472403 Verfahren zur Herstellung eines 4'-Demethyl-epipodophyllotoxins ⤷  Try a Trial
Brazil 6683006 ⤷  Try a Trial
Belgium 687089 ⤷  Try a Trial
Switzerland 459257 Verfahren zur Herstellung von 4'-Demethyl-epipodophyllotoxin ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.